EcoDrugPlus

Ensembl ID : ENSNBRG00000005336
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSNBRG00000015420
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSNBRG00000002552
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSNBRG00000018919
Gene Symbol: -
Cross references: -
238 Possible Orthologues:

Ensembl ID : ENSNBRG00000018940
Gene Symbol: -
Cross references: -
244 Possible Orthologues:

Ensembl ID : ENSNBRG00000010107
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSNBRG00000008789
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSNBRG00000015044
Gene Symbol: -
1 Cross references
184 Possible Orthologues:

Ensembl ID : ENSNBRG00000007108
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSNBRG00000007480
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSNBRG00000010543
Gene Symbol: -
Cross references: -
11 Possible Orthologues:

Ensembl ID : ENSNBRG00000001986
Gene Symbol: -
Cross references: -
151 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).